선택적 제품 분석
허용하는 경우 개인정보 보호를 고려한 제한적 분석을 사용해 어떤 리서치 여정이 효과적인지 파악합니다. 광고 추적기나 세션 녹화는 사용하지 않습니다. 환경설정에서 이 선택을 변경할 수 있습니다. 자세한 내용은 개인정보 처리방침.
Xylem Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $23.9B | |
|---|---|---|
| Revenue (ttm) | 9.1B | |
| Net income (ttm) | 1.1B | |
| EPS (ttm) | $4.52 | |
| Shares out | 229.3M | |
| P/E (trailing) | 19.6x | |
| P/E (forward) | 17.4x | |
| Dividend | $1.72 (1.95%) | |
| Volume | 10,128,601 | |
| Beta | 0.99 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $5.20B | $5.52B | $7.36B | $8.56B | $9.04B | +14.8% |
| Gross profit | $1.98B | $2.08B | $2.72B | $3.21B | $3.48B | +15.2% |
| Operating income | $585.0M | $622.0M | $652.0M | $1.01B | $1.22B | +20.2% |
| Net income | $427.0M | $355.0M | $609.0M | $890.0M | $957.0M | +22.4% |
| EPS (diluted) | $2.35 | $1.96 | $2.79 | $3.65 | $3.92 | +13.6% |
| EBITDA | $832.0M | $726.0M | $1.12B | $1.69B | $1.79B | +21.0% |
| R&D | $204.0M | $206.0M | $232.0M | $230.0M | $226.0M | +2.6% |
| SG&A | $1.18B | $1.23B | $1.76B | $1.91B | $1.92B | +13.0% |
Recent company headlines from major financial publishers.
In the base scenario, consolidated revenue expands at a moderate pace from $9,035,000,000 in FY2025 toward consensus FY2027 revenue of $9,620,179,580. Operating margins expand from 13.97% in FY2026 to 15.58% by FY2030, driven by operational productivity and 80/20 portfolio optimization. Applying a 9.36% cost of equity and a 17.0x terminal multiple yields an intrinsic fair value of $90.73.
In the bull scenario, accelerating adoption of AI data center liquid cooling systems and advanced industrial wastewater reuse drives multi-year organic revenue growth above 6%. Concurrently, rapid resolution of customer electric metering installation delays and enhanced 80/20 commercial execution unlock over 150 basis points of operating margin expansion, pushing operating margins toward 16.5%. Free cash flow conversion exceeds 100% of net income, supporting intrinsic valuation at the high end of the committee range ($102.86).
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 8.4% | $93.5 | $96.9 | $101 | $105 | $111 |
| 8.9% | $89.3 | $92.1 | $95.4 | $99.2 | $104 |
| 9.4% | $85.5 | $88.0 | $90.7 | $94.0 | $97.7 |
| 9.9% | $82.2 | $84.3 | $86.7 | $89.4 | $92.5 |
| 10.4% | $79.2 | $81.0 | $83.1 | $85.4 | $88.1 |
Upcoming earnings date and setup when available.
매월 발행된 리서치 판이 부여한 등급입니다. 등급은 분석 시점의 가격을 공정 가치와 비교한 것이며, 판단이 맞았는지에 대한 기록이 아닙니다.
| 연도 | 1월 | 2월 | 3월 | 4월 | 5월 | 6월 | 7월 | 8월 | 9월 | 10월 | 11월 | 12월 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |